{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:04:08Z","timestamp":1789902248407,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["UHB12779"],"award-info":[{"award-number":["UHB12779"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573708"],"award-info":[{"award-number":["82573708"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phrs.2026.108431","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:20:30Z","timestamp":1788452430000},"page":"108431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spatial atlas of upper tract urothelial carcinoma identifies SLC14A1\u202f+ and S100A8\/9+ tumor cells as key determinants of malignant progression"],"prefix":"10.1016","volume":"232","author":[{"given":"Jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diliyaer","family":"Dilixiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuShi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10147-014-0695-1","article-title":"Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy","volume":"20","author":"Fujita","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108431_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.21037\/tau.2016.03.23","article-title":"Why are upper tract urothelial carcinoma two different diseases?","volume":"5","author":"Szarvas","year":"2016","journal-title":"Transl. Androl. Urol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108431_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.urolonc.2014.02.018","article-title":"Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract","volume":"32","author":"Chung","year":"2014","journal-title":"Urol. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108431_bib9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00345-019-02739-1","article-title":"Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up","volume":"37","author":"Hasan","year":"2019","journal-title":"World J. Urol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108431_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15204987","article-title":"Upper Tract Urothelial Carcinoma (UTUC) diagnosis and risk stratification: a comprehensive review","volume":"15","author":"Bitaraf","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell."},{"issue":"8","key":"10.1016\/j.phrs.2026.108431_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41417-024-00779-3","article-title":"ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma","volume":"31","author":"Xin","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"18","key":"10.1016\/j.phrs.2026.108431_bib13","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.7150\/thno.77281","article-title":"Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma","volume":"12","author":"Liang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108431_bib14","article-title":"Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.phrs.2026.108431_bib15","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.7150\/ijbs.83098","article-title":"Novel insights from spatial transcriptome analysis in solid tumors","volume":"19","author":"Du","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"6190","key":"10.1016\/j.phrs.2026.108431_bib17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2026.108431_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108431_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106182","article-title":"Somatic structural variants drive upper tract urothelial carcinoma muscle invasiveness via activation of TPX2 transcription","volume":"125","author":"Xu","year":"2026","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12967-023-04815-y","article-title":"Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"7693","key":"10.1016\/j.phrs.2026.108431_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib24","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-021-25103-7","article-title":"An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer","volume":"12","author":"Gouin","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/endo-108-3-1083","article-title":"1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture","volume":"108","author":"Colston","year":"1981","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108431_bib26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ecl.2017.07.007","article-title":"Vitamin D Receptor Signaling and Cancer","volume":"46","author":"Campbell","year":"2017","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/nar\/gkq875","article-title":"Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1\/cip1) expression and function in non-malignant prostate cells","volume":"39","author":"Thorne","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/nar\/gkj460","article-title":"Regulation of the human p21(waf1\/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor","volume":"34","author":"Saram\u00e4ki","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib29","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/s41598-022-08091-6","article-title":"MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A\/\u03b2-catenin signaling","volume":"12","author":"Chung","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","article-title":"METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner","volume":"18","author":"Han","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13346-024-01648-0","article-title":"A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer","volume":"15","author":"Bisht","year":"2025","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib32","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jcb.27681","article-title":"Extracellular matrix (ECM) stiffness and degradation as cancer drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/1878-0261.12159","article-title":"Mammary epithelium-specific inactivation of V-ATPase reduces stiffness of extracellular matrix and enhances metastasis of breast cancer","volume":"12","author":"Katara","year":"2018","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108431_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12032-022-01751-7","article-title":"Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence","volume":"39","author":"Wang","year":"2022","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113795","article-title":"RING induces cell cycle arrest and apoptosis in human breast cancer cells by regulating the HSF1\/MT2A axis","volume":"433","author":"Liu","year":"2023","journal-title":"Exp. Cell. Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108431_bib36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/ijc.34288","article-title":"Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis","volume":"152","author":"Cheung","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.phrs.2026.108431_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911781","article-title":"Mini Review: Molecular Interpretation of the IGF\/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108431_bib38","article-title":"Integrin-\u03b19\u03b21 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.phrs.2026.108431_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/BJ20041444","article-title":"ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7","volume":"387","author":"Bridges","year":"2005","journal-title":"Biochem. J."},{"issue":"20","key":"10.1016\/j.phrs.2026.108431_bib40","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1074\/jbc.M609323200","article-title":"Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis","volume":"282","author":"Vlahakis","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108431_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1546382","article-title":"Integrative single-cell and spatial transcriptomics analysis reveals MDK-NCL pathway's role in shaping the immunosuppressive environment of lung adenocarcinoma","volume":"16","author":"Fu","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1203","article-title":"Single-cell transcriptomic analysis deciphers key transitional signatures associated with oncogenic evolution in human intramucosal oesophageal squamous cell carcinoma","volume":"13","author":"Liu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108431_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcancer.2023.11.008","article-title":"Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy","volume":"97","author":"Abou Khouzam","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-pathmechdis-111523-023520","article-title":"Roles of Cellular Neighborhoods in Hepatocellular Carcinoma Pathogenesis","volume":"20","author":"Ma","year":"2025","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108431_bib46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108431_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110962","article-title":"DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway","volume":"113","author":"Mi","year":"2024","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2026.108431_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110521","article-title":"Sustained systemic inflammation increases autophagy and induces EMT\/fibrotic changes in mouse liver cells: Protection by melatonin","volume":"101","author":"Chowdhury","year":"2023","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.phrs.2026.108431_bib51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41419-022-04688-x","article-title":"Therapeutic approaches targeting CD95L\/CD95 signaling in cancer and autoimmune diseases","volume":"13","author":"Risso","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-9966-33-3","article-title":"Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells","volume":"33","author":"Zhao","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","article-title":"Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5","volume":"12","author":"Kischkel","year":"2000","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cei\/uxab039","article-title":"Does CCL19 act as a double-edged sword in cancer development?","volume":"207","author":"Gowhari Shabgah","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108431_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jnci\/djn059","article-title":"Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy","volume":"100","author":"Wang","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.phrs.2026.108431_bib57","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.4049\/jimmunol.177.10.6713","article-title":"CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells","volume":"177","author":"Chunsong","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108431_bib58","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/cam4.1039","article-title":"CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway","volume":"6","author":"Xu","year":"2017","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108431_bib59","first-page":"679","article-title":"Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin \u03b1v\u03b23","volume":"27","author":"Li","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108431_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep30207","article-title":"Human breast cancer-derived soluble factors facilitate CCL19-induced chemotaxis of human dendritic cells","volume":"6","author":"Hwang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib61","doi-asserted-by":"crossref","first-page":"i30","DOI":"10.1093\/ndt\/gft430","article-title":"A perspective on anti-CCN2 therapy for chronic kidney disease","volume":"29","author":"Falke","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.phrs.2026.108431_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cdd.2012.136","article-title":"CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation","volume":"20","author":"Chang","year":"2013","journal-title":"Cell. Death Differ."},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/path.5007","article-title":"Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation","volume":"244","author":"Rayego-Mateos","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib64","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12672-025-02342-4","article-title":"Research progress on ADAM28 in malignant tumors","volume":"16","author":"Zhao","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.phrs.2026.108431_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104458","article-title":"SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4\/CXCL12 axis","volume":"371","author":"Fang","year":"2022","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108431_bib66","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.3892\/or.2013.2733","article-title":"CD14 regulates gastric cancer cell epithelial\u2011mesenchymal transition and invasion in vitro","volume":"30","author":"Li","year":"2013","journal-title":"Oncol. Rep."},{"issue":"15","key":"10.1016\/j.phrs.2026.108431_bib67","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.1424795112","article-title":"CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer","volume":"112","author":"Cheah","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2026.108431_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-014-9545-x","article-title":"Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis","volume":"34","author":"Schlesinger","year":"2015","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"6413","key":"10.1016\/j.phrs.2026.108431_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108431_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/srep38531","article-title":"FOXA1, GATA3 and PPAR\u0263 Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines","volume":"6","author":"Warrick","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108431_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117914","article-title":"S100A8\/A9: key regulatory factors in programmed cell death networks and disease progression","volume":"249","author":"Chen","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108431_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1187741","article-title":"The functions and regulatory pathways of S100A8\/A9 and its receptors in cancers","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108431_bib74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.31982","article-title":"Newly developed anti-S100A8\/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis","volume":"145","author":"Kinoshita","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2026.108431_bib75","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pros.21495","article-title":"Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)","volume":"72","author":"Jennbacken","year":"2012","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.phrs.2026.108431_bib76","article-title":"Down-regulation of SLC14A1 in prostate cancer activates CDK1\/CCNB1 and mTOR pathways and promotes tumor progression","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.phrs.2026.108431_bib77","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.7150\/thno.51655","article-title":"SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma","volume":"10","author":"Chan","year":"2020","journal-title":"Theranostics"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:58:43Z","timestamp":1789901923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"alternative-id":["S1043661826003464"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108431","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial atlas of upper tract urothelial carcinoma identifies SLC14A1\u202f+ and S100A8\/9+ tumor cells as key determinants of malignant progression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108431"}}